Dyne Therapeutics, Inc. DYN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

47/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Dyne Therapeutics, Inc. (DYN), dont 20 achats et 26 ventes. Le total des achats d'initiés s'élève à $18.34M et le total des ventes d'initiés à $11.85M.

Les initiés notables ayant une activité récente comprennent Lucera Erick, Posner Brian S, Kersten Dirk. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — DYN

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Lucera Erick	Chief Financial Officer	Vente Informative	5,727	$18.64	$106.75K	125,373
2026-03-30	Posner Brian S	Director	Achat Informatif	2,000	$17.08	$34.16K	15,500
2026-03-11	Posner Brian S	Director	Achat Informatif	2,000	$19.35	$38.7K	13,500
2026-03-11	Kersten Dirk	Director	Vente Informative	129,672	$19.52	$2.53M	4,644,386
2026-03-10	Kersten Dirk	Director	Vente Informative	281,858	$19.80	$5.58M	4,774,058
2026-03-09	Kersten Dirk	Director	Vente Informative	177,690	$17.72	$3.15M	5,285,156
2026-03-06	Posner Brian S	Director	Achat Informatif	3,000	$15.06	$45.18K	11,500
2026-03-05	Cox John	CEO & President	Vente Informative	2,732	$14.90	$40.71K	374,145
2026-03-05	Kerr Douglas	Chief Medical Officer	Vente Informative	904	$14.90	$13.47K	171,606
2026-03-05	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	148	$14.90	$2.21K	154,581
2026-02-12	Cox John	CEO & President	Attribution de RSU	285,000	$16.00	$4.56M	285,000
2026-02-12	Lucera Erick	Chief Financial Officer	Attribution de RSU	105,000	$16.00	$1.68M	105,000
2026-02-12	Kerr Douglas	Chief Medical Officer	Attribution de RSU	130,000	$16.00	$2.08M	130,000
2026-02-12	Friedl-naderer Johanna	Chief Commercial Officer	Attribution de RSU	90,000	$16.00	$1.44M	90,000
2025-12-22	Karnani Vikram	Officer	Inconnu	-	-	-	-
2025-12-22	Karnani Vikram	Director	Attribution de RSU	59,665	$20.78	$1.24M	59,665
2025-12-05	Cox John	CEO & President	Vente Informative	2,662	$20.72	$55.16K	196,877
2025-12-05	Kerr Douglas	Chief Medical Officer	Vente Informative	880	$20.72	$18.23K	87,510
2025-12-05	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	144	$20.72	$2.98K	94,729
2025-10-01	Posner Brian S	Director	Inconnu	-	-	-	8,500
2025-10-01	Posner Brian S	Director	Attribution de RSU	70,000	$12.50	$875K	70,000
2025-09-05	Kerr Douglas	Chief Medical Officer	Vente Informative	873	$13.41	$11.71K	88,390
2025-09-05	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	144	$13.41	$1.93K	94,873
2025-09-05	Cox John	CEO & President	Vente Informative	2,640	$13.41	$35.4K	199,539
2025-09-04	Kerr Douglas	Chief Medical Officer	Vente Informative	3,552	$13.27	$47.14K	89,263
2025-09-04	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	894	$13.27	$11.86K	95,017
2025-07-16	Cox John	CEO & President	Attribution de RSU	197,285	$9.33	$1.84M	197,285
2025-07-16	Kerr Douglas	Chief Medical Officer	Attribution de RSU	65,110	$9.33	$607.48K	65,110
2025-07-16	Friedl-naderer Johanna	Chief Commercial Officer	Attribution de RSU	51,255	$9.33	$478.21K	51,255
2025-07-15	Cox John	CEO & President	Don (Donné)	10,000	-	-	202,179
2025-07-14	Cox John	CEO & President	Achat Informatif	100,000	$9.11	$911K	242,179
2025-06-05	Cox John	CEO & President	Vente Informative	4,060	$13.35	$54.2K	142,179
2025-06-05	Kerr Douglas	Chief Medical Officer	Vente Informative	1,342	$13.35	$17.92K	92,815
2025-06-05	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	146	$13.35	$1.95K	95,911
2025-05-30	Hurwitz Edward	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-05-30	Lubner David Charles	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-05-30	Rhodes Jason P	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-05-30	Stehman-breen Catherine	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-05-30	Kersten Dirk	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-05-30	Incerti Carlo	Director	Attribution de RSU	35,000	$11.96	$418.6K	35,000
2025-03-31	Lucera Erick	Officer	Inconnu	-	-	-	-
2025-03-31	Lucera Erick	Chief Financial Officer	Attribution de RSU	66,100	-	-	66,100
2025-03-13	Friedl-naderer Johanna	Chief Commercial Officer	Vente Informative	143	$12.12	$1.73K	96,057
2025-03-11	Scalzo Richard William	SVP, Head of Finance & Admin.	Vente Informative	1,343	$11.38	$15.28K	122,330
2025-03-11	Beskrovnaya Oxana	Chief Scientific Officer	Vente Informative	2,153	$11.38	$24.5K	195,840
2025-03-05	Cox John	CEO & President	Vente Informative	4,061	$11.83	$48.04K	146,239
2025-03-05	Scalzo Richard William	SVP, Head of Finance & Admin.	Vente Informative	917	$11.83	$10.85K	123,673
2025-03-05	Kerr Douglas	Chief Medical Officer	Vente Informative	1,343	$11.83	$15.89K	94,157
2025-03-05	Beskrovnaya Oxana	Chief Scientific Officer	Vente Informative	1,094	$11.83	$12.94K	197,993
2025-02-18	Scalzo Richard William	SVP, Head of Finance & Admin.	Vente Informative	2,488	$13.95	$34.71K	124,590

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration